This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
ASTS Reports Wider-Than-Expected Q2 Loss Despite Top-Line Growth
by Zacks Equity Research
AST SpaceMobile posts wider-than-estimated Q2 loss as higher costs and macro headwinds offset modest revenue growth.
WDAYNegative Net Change KEYSNegative Net Change CMBMNegative Net Change ASTSNegative Net Change
artificial-intelligence communications earnings iot mobile tech-stocks
Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus
by Zacks Equity Research
IMVT reports a narrower Q1 loss, as spotlight remains on IMVT-1402's broad clinical potential across multiple indications.
CRMDNegative Net Change ZYMEPositive Net Change IMVTNegative Net Change ALVONegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
by Zacks Equity Research
XENE's wider Q2 loss highlights its push toward late-stage epilepsy, depression, and bipolar disorder studies with azetukalner.
NBIXNegative Net Change CRMDNegative Net Change XENENegative Net Change ALVONegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
YPF Q2 Earnings & Revenues Miss Estimates on Lower Crude Production
by Zacks Equity Research
Lower crude output and weaker oil prices lay pressure on upstream results, hurting YPF's Q2 earnings.
AMNegative Net Change ENBPositive Net Change YPFNegative Net Change GLPEYNegative Net Change
earnings energy oil-energy
Auna S.A. (AUNA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AUNAPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
PagSeguro Digital Ltd. (PAGS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
PagSeguro Digital (PAGS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PAGSNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Amer Sports, Inc. (AS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Amer Sports, Inc. (AS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ASNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Home Depot (HD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Home Depot (HD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Viking Holdings (VIK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Viking (VIK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VIKNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Civitas Q2 Earnings and Revenues Miss Estimates, Both Fall Y/Y
by Zacks Equity Research
CIVI's second-quarter earnings and revenues fell short on weaker oil prices, but asset sales, buybacks and debt cuts strengthen its outlook.
IMONegative Net Change TRPPositive Net Change CIVIPositive Net Change CTRANegative Net Change
earnings energy oil-energy
Helmerich & Payne Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HP's third-quarter earnings beat estimates despite a sharp drop from last year due to weakness in the International Solutions segment.
HPPositive Net Change IMONegative Net Change TRPPositive Net Change CTRANegative Net Change
earnings energy oil-energy
Is Cisco Systems (CSCO) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
by Bryan Hayes
Strong demand for Cisco's products in developing AI infrastructure has been a game changer.
CSCONegative Net Change
artificial-intelligence communications computers cybersecurity dividends earnings electronics infrastructure investing software stock-performance tech-stocks
Dun & Bradstreet (DNB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Dun & Bradstreet (DNB) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
DNBNo Net Change
earnings earnings-estimates-revisions earnings-surprise
International Markets and Lam Research (LRCX): A Deep Dive for Investors
by Zacks Equity Research
Explore Lam Research's (LRCX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
LRCXPositive Net Change
earnings geographic-revenue
Deciphering MKS (MKSI) International Revenue Trends
by Zacks Equity Research
Explore how MKS' (MKSI) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
MKSINegative Net Change
earnings geographic-revenue
Watts Water (WTS) International Revenue Performance Explored
by Zacks Equity Research
Evaluate Watts Water's (WTS) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
WTSPositive Net Change
earnings geographic-revenue
GoPro's Q2 Loss Wider Than Expected, Revenues Down Y/Y
by Zacks Equity Research
GPRO tops Q2 revenue forecasts despite sales drop, aiming for growth rebound with upcoming hardware and software launches.
DLBNo Net Change GPRONegative Net Change SONONegative Net Change SONYNegative Net Change
earnings tech-stocks
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
by Zacks Equity Research
Exact Sciences tops on Q2 earnings and revenue estimates and raises the 2025 outlook, but shares slide 8% after results.
BSXPositive Net Change EXASPositive Net Change MEDPNegative Net Change WGSNegative Net Change
earnings medical medical-devices
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
by Zacks Equity Research
PODD posts strong Q2 earnings and revenues and lifts its 2025 outlook, marking a decade of 20%+ constant-currency growth.
BSXPositive Net Change PODDPositive Net Change MEDPNegative Net Change WGSNegative Net Change
earnings medical medical-devices
EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up
by Zacks Equity Research
National Vision tops on Q2 earnings and revenues, boosts 2025 guidance after strong sales and margin expansion.
CAHNegative Net Change MEDPNegative Net Change EYENegative Net Change WGSNegative Net Change
earnings medical
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up
by Zacks Equity Research
Veracyte Q2 earnings and revenues beat estimates, fueled by Decipher and Afirma growth, sending shares up over 15%.
CAHNegative Net Change VCYTNegative Net Change MEDPNegative Net Change WGSNegative Net Change
earnings medical
DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26
by Zacks Equity Research
Denali Therapeutics posts narrower-than-expected Q2 loss. The company advances multiple rare disease therapies toward potential approvals.
BIIBPositive Net Change BAYRYPositive Net Change CRMDNegative Net Change DNLINegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Delek Q2 Loss Narrower Than Expected, Revenues Miss Estimates
by Zacks Equity Research
DK expects total crude throughput in the range of 291,000-306,000 bpd and total throughput in the band of 302,000-317,000 bpd for third-quarter 2025.
HALNegative Net Change VLOPositive Net Change DKPositive Net Change DKLNegative Net Change
earnings energy oil-energy
On Holding (ONON) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
On Holding (ONON) delivered earnings and revenue surprises of -145.83% and +6.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ONONNegative Net Change XELBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Compared to Estimates, Strategic Education (STRA) Q2 Earnings: A Look at Key Metrics (Revised)
by Zacks Equity Research
The headline numbers for Strategic Education (STRA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
STRAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise